These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 38924824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Song J, Xue YQ, Wang YJ, Xu P, Sun DK, Chen W.
    World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
    [Abstract] [Full Text] [Related]

  • 3. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
    Wang X, Li YM, Li WQ, Huang CG, Lu YC, Hou LJ.
    PLoS One; 2012 Mar; 7(10):e47778. PubMed ID: 23082215
    [Abstract] [Full Text] [Related]

  • 4. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A, CONSCIOUS-1 Investigators.
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
    Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY.
    J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clazosentan for Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis with Trial Sequential Analysis.
    Cho SS, Kim SE, Kim HC, Kim WJ, Jeon JP.
    World Neurosurg; 2019 Mar; 123():418-424.e3. PubMed ID: 30508597
    [Abstract] [Full Text] [Related]

  • 11. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
    Mayer SA, Aldrich EF, Bruder N, Hmissi A, Macdonald RL, Viarasilpa T, Marr A, Roux S, Higashida RT.
    Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Clazosentan After Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis.
    Pontes JPM, Santos MDC, Gibram FC, Rodrigues NMV, Cavalcante-Neto JF, Barros ADM, Solla DJF.
    Neurosurgery; 2023 Dec 01; 93(6):1208-1219. PubMed ID: 37462365
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
    Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O, Tominaga T.
    J Neurosurg; 2022 Dec 01; 137(6):1707-1717. PubMed ID: 35364589
    [Abstract] [Full Text] [Related]

  • 18. Clazosentan: prevention of cerebral vasospasm and the potential to overcome infarction.
    Beck J, Raabe A.
    Acta Neurochir Suppl; 2011 Dec 01; 110(Pt 2):147-50. PubMed ID: 21125461
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dissociation of vasospasm and secondary effects of experimental subarachnoid hemorrhage by clazosentan.
    Sabri M, Ai J, Macdonald RL.
    Stroke; 2011 May 01; 42(5):1454-60. PubMed ID: 21454820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.